Humana Inc. (NYSE: HUM) CEO Bruce Broussard will step down in late 2024, with incoming COO and President Jim Rechtin on deck to succeed him. Rechtin comes to Humana from Envision Healthcare where he is now president and CEO. He transitions to the COO role for the insurance behemoth as of Jan. 8, 2024 and […]
TPG Capital
A recent federal court decision that cleared the way for UnitedHealth Group’s (NYSE: UNH) forthcoming purchase of Change Healthcare (NASDAQ: CHNG) is a positive sign for the insurance company’s pending acquisition of LHC Group (NASDAQ: LHCG). The U.S. Department of Justice sought to block the $13 billion Change Healthcare transaction on anti-trust grounds, alleging that […]
Humana Inc. (NYSE: HUM) has completed its $2.8 billion sale of Kindred at Home’s hospice and personal care segments, divesting a 60% stake to the private equity firm Clayton, Dubilier & Rice. Humana will retain the remaining 40%. The sale coincides with Humana’s stated goal of raising its enterprise value by $1 billion, while building […]
Two Oregon locations included in Humana’s (NYSE: HUM) divestiture of Kindred at Home’s hospice assets are currently under review by the state’s health authority — part of the diligence process involved in any M&A transaction. Humana in April signed a definitive agreement to sell a 60% stake in Kindred at Home to private equity firm […]
Private equity firms are pouring investment dollars into hospices at a record pace. Meanwhile, legislators and regulators as far up as the White House are taking aim at those firms. Despite a cool down in the hospice mergers and acquisitions market during the first quarter of 2022, private equity firms have stayed aggressive on deals. […]
The post-acute technology company WellSky is spreading its wings over new geographies while growing its client base and expanding its product portfolio. Underlying the company’s strategy is a drive to develop solutions designed to support patient care as consumers navigate their way through the health care system. WellSky is jointly owned by two private equity […]
In its calculus behind its 2021 Kindred at Home deal, Humana Inc. (NYSE: HUM) had to weigh the potential cost savings and lucrative hospice divestiture against the labor pressures in the space, as well as the complexity of scaling home-based care in a fragmented industry. Last year, Humana acquired total ownership of Kindred at Home […]
The Southern District Court of Mississippi granted hospice provider SouthernCare Inc.’s motion to dismiss a whistleblower’s False Claims Act complaint. However, the court will proceed in hearing allegations that the company terminated an employee who raised concerns about these practices. Former SouthernCare nurse Rhonda McClinton filed a qui tam complaint against the organization in 2016, […]
Humana Inc. (NYSE: HUM) has signed a definitive agreement to sell a 60% stake in Kindred at Home’s (KAH) hospice and personal care business to the private equity firm Clayton, Dubilier & Rice (CDR) for $2.8 billion. Humana will retain the remaining 40%. Kindred at Home has been on a circuitous journey with Humana. The […]
Mergers-and-acquisition activity continues to boom in the hospice space this year. Deal volume may exceed the record number from the prior two years. As many as 61% of the 203 hospice care professionals who responded to a recent Hospice News Outlook Survey and Report said they anticipate that hospice M&A activity will increase during 2022. […]